New LSU President to visit LSU Eunice campus
Louisiana State University
and last updated 2021-07-09 19:59:42-04
The new LSU President will make his first official visit to the LSU Eunice campus on Tuesday, July 13.
Dr. William Tate IV replaces LSU President Tom Galligan, who has served as president since January 2020, they say.
According to a press release, Galligan, who was bestowed the title of President Emeritus, will return to faculty at the LSU Law School.
Tate has served as Executive Vice President for Academic Affairs and Provost at the University of South Carolina since July 2020.
He received his Ph.D. in mathematics education from the University of Maryland, they say, as well as a Master of Arts in Teaching from the University of Texas at Dallas, Master of Psychiatric Epidemiology from Washington University School of Medicine, and Bachelor of Science in economics from Northern Illinois University.
Researchers identify potential new treatment targets for Alzheimer s disease
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets.
The potential targets are defective proteins that lead to the buildup of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s. The 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
Cruchaga lab
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs with therapeutic potential.
The targets are defective proteins, and the 15 existing drugs identified by the researchers have been approved by the Food and Drug Administration (FDA) for other purposes, providing the possibility of clinical trials that could begin sooner than is typical, according to the researchers.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer’s disease, as well as existing drugs that have therapeutic potential against these targets.
Study identifies potential new treatment targets for Alzheimer s disease ANI | Updated: Jul 09, 2021 08:56 IST
Washington [US], July 9 (ANI): Potential new treatment targets for Alzheimer s disease, as well as existing drugs that have therapeutic potential against these targets, have been identified by a research team at Washington University School of Medicine in St Louis.
The new study, funded by the National Institute on Aging of the National Institutes of Health (NIH), was published in the journal Nature Neuroscience.
The potential targets are defective proteins that lead to the build-up of amyloid in the brain, contributing to the onset of problems with memory and thinking that are the hallmark of Alzheimer s.
Meet the First Black Female Chair of Surgery at a U S Academic Health Science Center blackenterprise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blackenterprise.com Daily Mail and Mail on Sunday newspapers.